Logo image of MET

METLIFE INC (MET) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MET - US59156R1086 - Common Stock

80.3 USD
-0.75 (-0.93%)
Last: 12/26/2025, 8:04:00 PM
80.3 USD
0 (0%)
After Hours: 12/26/2025, 8:04:00 PM
Fundamental Rating

4

Overall MET gets a fundamental rating of 4 out of 10. We evaluated MET against 148 industry peers in the Insurance industry. MET may be in some trouble as it scores bad on both profitability and health. MET is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

MET had positive earnings in the past year.
MET had a positive operating cash flow in the past year.
MET had positive earnings in each of the past 5 years.
Each year in the past 5 years MET had a positive operating cash flow.
MET Yearly Net Income VS EBIT VS OCF VS FCFMET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

1.2 Ratios

MET has a worse Return On Assets (0.50%) than 71.62% of its industry peers.
MET has a Return On Equity of 12.56%. This is comparable to the rest of the industry: MET outperforms 56.76% of its industry peers.
The Return On Invested Capital of MET (0.64%) is worse than 67.57% of its industry peers.
MET had an Average Return On Invested Capital over the past 3 years of 0.52%. This is significantly below the industry average of 14.88%.
The last Return On Invested Capital (0.64%) for MET is above the 3 year average (0.52%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.5%
ROE 12.56%
ROIC 0.64%
ROA(3y)0.39%
ROA(5y)0.53%
ROE(3y)9.29%
ROE(5y)8.85%
ROIC(3y)0.52%
ROIC(5y)0.65%
MET Yearly ROA, ROE, ROICMET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MET has a worse Profit Margin (5.05%) than 65.54% of its industry peers.
In the last couple of years the Profit Margin of MET has declined.
MET's Operating Margin of 8.34% is on the low side compared to the rest of the industry. MET is outperformed by 66.89% of its industry peers.
MET's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.34%
PM (TTM) 5.05%
GM N/A
OM growth 3Y-9.41%
OM growth 5Y-3.49%
PM growth 3Y-12.69%
PM growth 5Y-6.22%
GM growth 3YN/A
GM growth 5YN/A
MET Yearly Profit, Operating, Gross MarginsMET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MET is destroying value.
MET has less shares outstanding than it did 1 year ago.
MET has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, MET has a worse debt to assets ratio.
MET Yearly Shares OutstandingMET Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
MET Yearly Total Debt VS Total AssetsMET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

The Debt to FCF ratio of MET is 1.36, which is an excellent value as it means it would take MET, only 1.36 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.36, MET is in the better half of the industry, outperforming 62.16% of the companies in the same industry.
A Debt/Equity ratio of 0.69 indicates that MET is somewhat dependend on debt financing.
The Debt to Equity ratio of MET (0.69) is worse than 84.46% of its industry peers.
Although MET does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 1.36
Altman-Z N/A
ROIC/WACC0.08
WACC7.59%
MET Yearly LT Debt VS Equity VS FCFMET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
MET Yearly Current Assets VS Current LiabilitesMET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 5.51% over the past year.
Measured over the past 5 years, MET shows a small growth in Earnings Per Share. The EPS has been growing by 5.91% on average per year.
The Revenue has been growing slightly by 0.79% in the past year.
Measured over the past years, MET shows a small growth in Revenue. The Revenue has been growing by 0.37% on average per year.
EPS 1Y (TTM)5.51%
EPS 3Y-3.75%
EPS 5Y5.91%
EPS Q2Q%21.54%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y-0.02%
Revenue growth 5Y0.37%
Sales Q2Q%1.63%

3.2 Future

The Earnings Per Share is expected to grow by 11.82% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.27% on average over the next years.
EPS Next Y7.88%
EPS Next 2Y11.39%
EPS Next 3Y11.66%
EPS Next 5Y11.82%
Revenue Next Year11.33%
Revenue Next 2Y3.4%
Revenue Next 3Y3.37%
Revenue Next 5Y4.27%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MET Yearly Revenue VS EstimatesMET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B 80B
MET Yearly EPS VS EstimatesMET Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.53 indicates a reasonable valuation of MET.
Compared to the rest of the industry, the Price/Earnings ratio of MET indicates a somewhat cheap valuation: MET is cheaper than 66.22% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.57. MET is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 7.95, which indicates a rather cheap valuation of MET.
71.62% of the companies in the same industry are more expensive than MET, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, MET is valued rather cheaply.
Industry RankSector Rank
PE 9.53
Fwd PE 7.95
MET Price Earnings VS Forward Price EarningsMET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MET is valued a bit cheaper than 62.84% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MET is valued a bit cheaper than the industry average as 79.05% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.62
EV/EBITDA 7.61
MET Per share dataMET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.21
PEG (5Y)1.61
EPS Next 2Y11.39%
EPS Next 3Y11.66%

5

5. Dividend

5.1 Amount

MET has a Yearly Dividend Yield of 2.78%.
Compared to an average industry Dividend Yield of 2.30, MET pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.88, MET pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.78%

5.2 History

The dividend of MET has a limited annual growth rate of 4.59%.
MET has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of MET decreased in the last 3 years.
Dividend Growth(5Y)4.59%
Div Incr Years2
Div Non Decr Years2
MET Yearly Dividends per shareMET Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

46.97% of the earnings are spent on dividend by MET. This is a bit on the high side, but may be sustainable.
MET's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP46.97%
EPS Next 2Y11.39%
EPS Next 3Y11.66%
MET Yearly Income VS Free CF VS DividendMET Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B
MET Dividend Payout.MET Dividend Payout, showing the Payout Ratio.MET Dividend Payout.PayoutRetained Earnings

METLIFE INC

NYSE:MET (12/26/2025, 8:04:00 PM)

After market: 80.3 0 (0%)

80.3

-0.75 (-0.93%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-03 2026-02-03/amc
Inst Owners76.54%
Inst Owner Change5.36%
Ins Owners0.18%
Ins Owner Change0.39%
Market Cap52.91B
Revenue(TTM)71.96B
Net Income(TTM)3.63B
Analysts80
Price TargetN/A
Short Float %1.69%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield 2.78%
Yearly Dividend2.43
Dividend Growth(5Y)4.59%
DP46.97%
Div Incr Years2
Div Non Decr Years2
Ex-Date11-04 2025-11-04 (0.5675)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.86%
Min EPS beat(2)-6.87%
Max EPS beat(2)1.16%
EPS beat(4)1
Avg EPS beat(4)-2.58%
Min EPS beat(4)-6.87%
Max EPS beat(4)1.16%
EPS beat(8)3
Avg EPS beat(8)-1.62%
EPS beat(12)4
Avg EPS beat(12)-2.92%
EPS beat(16)8
Avg EPS beat(16)4.65%
Revenue beat(2)0
Avg Revenue beat(2)-5.03%
Min Revenue beat(2)-5.79%
Max Revenue beat(2)-4.27%
Revenue beat(4)2
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-5.79%
Max Revenue beat(4)2.63%
Revenue beat(8)3
Avg Revenue beat(8)-2.34%
Revenue beat(12)5
Avg Revenue beat(12)-1.97%
Revenue beat(16)6
Avg Revenue beat(16)-1.99%
PT rev (1m)-1.2%
PT rev (3m)0.41%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)-0.34%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)0.7%
Revenue NQ rev (1m)6.74%
Revenue NQ rev (3m)34.27%
Revenue NY rev (1m)8.15%
Revenue NY rev (3m)8.47%
Valuation
Industry RankSector Rank
PE 9.53
Fwd PE 7.95
P/S 0.74
P/FCF 3.62
P/OCF 3.62
P/B 1.83
P/tB 2.67
EV/EBITDA 7.61
EPS(TTM)8.43
EY10.5%
EPS(NY)10.1
Fwd EY12.58%
FCF(TTM)22.2
FCFY27.65%
OCF(TTM)22.2
OCFY27.65%
SpS109.21
BVpS43.93
TBVpS30.12
PEG (NY)1.21
PEG (5Y)1.61
Graham Number91.28
Profitability
Industry RankSector Rank
ROA 0.5%
ROE 12.56%
ROCE 0.83%
ROIC 0.64%
ROICexc 0.66%
ROICexgc 0.97%
OM 8.34%
PM (TTM) 5.05%
GM N/A
FCFM 20.33%
ROA(3y)0.39%
ROA(5y)0.53%
ROE(3y)9.29%
ROE(5y)8.85%
ROIC(3y)0.52%
ROIC(5y)0.65%
ROICexc(3y)0.53%
ROICexc(5y)0.66%
ROICexgc(3y)0.78%
ROICexgc(5y)0.97%
ROCE(3y)0.68%
ROCE(5y)0.84%
ROICexgc growth 3Y-6.12%
ROICexgc growth 5Y-2.06%
ROICexc growth 3Y-5.87%
ROICexc growth 5Y-1.33%
OM growth 3Y-9.41%
OM growth 5Y-3.49%
PM growth 3Y-12.69%
PM growth 5Y-6.22%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 1.36
Debt/EBITDA 2.95
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 5.77
Cash Conversion 217.79%
Profit Quality 402.5%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.59%
ROIC/WACC0.08
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)633.54%
Profit Quality(5y)464.62%
High Growth Momentum
Growth
EPS 1Y (TTM)5.51%
EPS 3Y-3.75%
EPS 5Y5.91%
EPS Q2Q%21.54%
EPS Next Y7.88%
EPS Next 2Y11.39%
EPS Next 3Y11.66%
EPS Next 5Y11.82%
Revenue 1Y (TTM)0.79%
Revenue growth 3Y-0.02%
Revenue growth 5Y0.37%
Sales Q2Q%1.63%
Revenue Next Year11.33%
Revenue Next 2Y3.4%
Revenue Next 3Y3.37%
Revenue Next 5Y4.27%
EBIT growth 1Y-4.29%
EBIT growth 3Y-9.43%
EBIT growth 5Y-3.13%
EBIT Next Year17.1%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.94%
FCF growth 3Y5.04%
FCF growth 5Y1.15%
OCF growth 1Y34.94%
OCF growth 3Y5.04%
OCF growth 5Y1.15%

METLIFE INC / MET FAQ

What is the fundamental rating for MET stock?

ChartMill assigns a fundamental rating of 4 / 10 to MET.


What is the valuation status of METLIFE INC (MET) stock?

ChartMill assigns a valuation rating of 6 / 10 to METLIFE INC (MET). This can be considered as Fairly Valued.


What is the profitability of MET stock?

METLIFE INC (MET) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for MET stock?

The Earnings per Share (EPS) of METLIFE INC (MET) is expected to grow by 7.88% in the next year.


How sustainable is the dividend of METLIFE INC (MET) stock?

The dividend rating of METLIFE INC (MET) is 5 / 10 and the dividend payout ratio is 46.97%.